Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 210778
Company: GLENMARK PHARMS LTD

Products on ANDA 210778

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
CLINDAMYCIN PHOSPHATE	CLINDAMYCIN PHOSPHATE	1%	AEROSOL, FOAM;TOPICAL	Prescription	AT	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 210778

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/20/2021	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 210778

CLINDAMYCIN PHOSPHATE

AEROSOL, FOAM;TOPICAL; 1%
TE Code = AT

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
CLINDAMYCIN PHOSPHATE	CLINDAMYCIN PHOSPHATE	1%	AEROSOL, FOAM;TOPICAL	Prescription	No	AT	210778	GLENMARK PHARMS LTD
CLINDAMYCIN PHOSPHATE	CLINDAMYCIN PHOSPHATE	1%	AEROSOL, FOAM;TOPICAL	Prescription	No	AT	090785	PADAGIS ISRAEL
CLINDAMYCIN PHOSPHATE	CLINDAMYCIN PHOSPHATE	1%	AEROSOL, FOAM;TOPICAL	Prescription	No	AT	210004	TARO